Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02756338 · ClinicalTrials.gov registry record
BioMonitor 2 In-Office Setting Insertion Safety and Feasibility Evaluation With Device Functionality Assessment
A clinical trial, sponsored by Biotronik.
- Completed
- Registry status
- 77
- Enrollment target
NCT02756338: Completed study, sponsored by Biotronik.
NCT02756338 is a clinical trial that has completed, run by Biotronik. The registered enrollment target is 77 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02756338 has completed, sponsored by Biotronik.
- COMPLETED
- Registry status
- 77 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and feasibility of performing the BioMonitor 2 insertion procedure in an office setting.
Primary Outcome
In order to be included in the primary objective analysis, insertion procedure-related adverse events must also include resolution by invasive action such as device removal, device replacement, surgical repositioning of the device, or another surgery preformed related to the device or primary insertion procedure.
Interventions
- DEVICE BioMonitor 2 Insertable Cardiac Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2016-06 |
| Est. Completion | 2017-07 |
What the finished NCT02756338 record still lists
NCT02756338 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 77 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which BioMonitor 2 Insertable Cardiac Monitor is the first listed.
NCT02756338 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02756338 about?
NCT02756338 is a clinical study titled "BioMonitor 2 In-Office Setting Insertion Safety and Feasibility Evaluation With Device Functionality Assessment". The purpose of this study is to evaluate the safety and feasibility of performing the BioMonitor 2 insertion procedure in an office setting.
What is the current status of trial NCT02756338?
This trial is currently completed. The enrollment target is 77 participants. The study started on 2016-06. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02756338?
The interventions under investigation include: BioMonitor 2 Insertable Cardiac Monitor (DEVICE).
Who is sponsoring clinical trial NCT02756338?
This trial is sponsored by Biotronik, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia